Structural Dynamics and Molecular Evolution of the SARS-CoV-2 Spike Protein.
Kyle A WolfJason C KwanJeremy P KamilPublished in: mBio (2022)
The ongoing coronavirus disease 2019 (COVID-19) pandemic demonstrates the threat posed by novel coronaviruses to human health. Coronaviruses share a highly conserved cell entry mechanism mediated by the spike protein, the sole product of the S gene. The structural dynamics by which the spike protein orchestrates infection illuminate how antibodies neutralize virions and how S mutations contribute to viral fitness. Here, we review the process by which spike engages its proteinaceous receptor, angiotensin converting enzyme 2 (ACE2), and how host proteases prime and subsequently enable efficient membrane fusion between virions and target cells. We highlight mutations common among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern and discuss implications for cell entry. Ultimately, we provide a model by which sarbecoviruses are activated for fusion competency and offer a framework for understanding the interplay between humoral immunity and the molecular evolution of the SARS-CoV-2 Spike. In particular, we emphasize the relevance of the Canyon Hypothesis (M. G. Rossmann, J Biol Chem 264:14587-14590, 1989) for understanding evolutionary trajectories of viral entry proteins during sustained intraspecies transmission of a novel viral pathogen.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- angiotensin converting enzyme
- human health
- coronavirus disease
- angiotensin ii
- risk assessment
- protein protein
- binding protein
- copy number
- immune response
- genome wide
- cell therapy
- body composition
- stem cells
- gene expression
- physical activity
- climate change
- small molecule
- dna methylation
- mesenchymal stem cells
- single molecule
- cell proliferation
- candida albicans
- genome wide identification